A Phase 1 Study of SAIL66 in Patients With CLDN6-positive Locally Advanced or Metastatic Solid Tumors

MUSC Hollings Cancer Center, Charleston

Georgia Cancer Center at Augusta University, Augusta

Tennessee Oncology, PLLC, Nashville

The University of Texas MD Anderson Cancer Center, Houston

Banner MD Anderson Cancer Center, Gilbert

National Cancer Center Hospital East, Kashiwa

National Cancer Center Hospital, Tokyo

Cancer Institute Hospital of JFCR, Tokyo

Shizuoka Cancer Center, Shizuoka